Biozipcode™ is a peptide-based drug delivery technology that attaches a “cell-specific postal code” to drugs or diagnostic probes, enabling them to reach only the intended target cells.
From combinations of 20 amino acids, seven-digit sequences are designed—yielding over 1.3 billion theoretical combinations—and a code is selected that can be uniquely recognized by the target cell.
When a drug or probe is tagged with this code, it circulates through blood or cerebrospinal fluid without interacting with other tissues. Once it reaches the target cell, membrane receptors recognize the code and initiate uptake.
As a result, the system maximizes therapeutic efficacy while minimizing side effects.
Currently, the technology is being explored for multiple applications, including curative therapies for diabetes (via abnormal hematopoietic stem cell reset), low-toxicity cancer and autoimmune disease treatments, and high-precision biomarker detection.
